Experimental Drug Shows Early Promise Against Sickle Cell Disease

WEDNESDAY, June 19, 2019 — An experimental drug for sickle cell disease reduced anemia and boosted the health of red blood cells in patients, according to a new study.
Whether the drug, voxelotor, will have long-term health benefits to patients…
Source: Topamax